Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Breast cancer, female
Trial Type:  Prevention
Results 1-7 of 7 for your search:
Start Over
Continuous or Intermittent Letrozole in Treating Postmenopausal Patients With Hormone Receptor-Positive Early Stage Breast Cancer
Phase: Phase III
Type: Prevention
Age: Postmenopausal
Trial IDs: 10-356, NCI-2011-00739, IBCSG-35-07, BIG-1-07-SOLE, EUDRACT-2007-001370-88, EU-20772, NCT00553410
Metformin Hydrochloride in Preventing Breast Cancer in Patients with Atypical Hyperplasia or In Situ Breast Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention, Treatment
Age: 25 to 55
Trial IDs: A211102, NCI-2013-00995, CALGB-A211102, NCT01905046
Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 25 and over
Trial IDs: 08218, NCI-2010-01976, 115422, NCT01196936
Dasatinib in Preventing Second Primary Breast Cancer in Women with Estrogen Receptor Negative Breast Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: 2010-0794, NCI-2012-00037, KG09 1020, Susan Komen Foundation Grant Number(s): KG09 1020, NCT01471106
Docosahexaenoic Acid in Preventing Recurrence in Breast Cancer Survivors
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: 2011-0766, NCI-2013-00859, 12-267, 12-474, AAAK6752, H-33017, MSKCC-12-267, N01-CN-2012-00034, MDA10-16-01, NCT01849250
Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 to 75
Trial IDs: IUCRO-0365, NCI-2013-00422, NCT01793948
Curcumin in Reducing Inflammatory Changes in Breast Tissue in Obese Patients At High Risk for Breast Cancer
Phase: No phase specified
Type: Prevention
Age: 19 and over
Trial IDs: OSU-13034, NCI-2013-01199, 2013C0039, NCT01975363
Start Over